Report Detail

Request for Sample of this report

Pharma & Healthcare Global Medication for Hair Loss Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4677905
    • |
  • 26 February, 2026
    • |
  • Global
    • |
  • 132 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Medication for Hair Loss market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Medications for hair loss are pharmaceutical products designed to prevent and treat excessive hair shedding or baldness caused by various factors. These drugs work through a variety of mechanisms such as regulating the scalp microenvironment, improving blood circulation to the scalp, enhancing follicular activity, inhibiting the effects of androgens on hair follicles, supplementing essential nutrients, and restoring internal body balance (such as kidney essence and liver blood in Traditional Chinese Medicine concepts) to reduce hair loss, promote hair growth, and maintain healthy hair.
This report is a detailed and comprehensive analysis for global Medication for Hair Loss market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medication for Hair Loss market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medication for Hair Loss market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medication for Hair Loss market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medication for Hair Loss market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medication for Hair Loss
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medication for Hair Loss market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Giuliani, Bayer AG, J&J, Taisho Pharma, Organon, Pfizer, P&G, Merck, 3SBio, DrFormulas, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medication for Hair Loss market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
External Medicine
Oral Medicine
Others
Market segment by Application
Pharmacy
Hospital
Online Channel
Major players covered
Giuliani
Bayer AG
J&J
Taisho Pharma
Organon
Pfizer
P&G
Merck
3SBio
DrFormulas
Beijing Hanmi Pharmaceutical Co., Ltd.
Hims & Hers Health, Inc.
Zhejiang Conba Pharmaceutical Co.,Ltd.
Nutraceutical Wellness, Inc.
Renhe Pharmacy Co.,Ltd.
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medication for Hair Loss product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medication for Hair Loss, with price, sales quantity, revenue, and global market share of Medication for Hair Loss from 2021 to 2026.
Chapter 3, the Medication for Hair Loss competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medication for Hair Loss breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medication for Hair Loss market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medication for Hair Loss.
Chapter 14 and 15, to describe Medication for Hair Loss sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medication for Hair Loss Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 External Medicine
    • 1.3.3 Oral Medicine
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medication for Hair Loss Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmacy
    • 1.4.3 Hospital
    • 1.4.4 Online Channel
  • 1.5 Global Medication for Hair Loss Market Size & Forecast
    • 1.5.1 Global Medication for Hair Loss Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Medication for Hair Loss Sales Quantity (2021-2032)
    • 1.5.3 Global Medication for Hair Loss Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Giuliani
    • 2.1.1 Giuliani Details
    • 2.1.2 Giuliani Major Business
    • 2.1.3 Giuliani Medication for Hair Loss Product and Services
    • 2.1.4 Giuliani Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Giuliani Recent Developments/Updates
  • 2.2 Bayer AG
    • 2.2.1 Bayer AG Details
    • 2.2.2 Bayer AG Major Business
    • 2.2.3 Bayer AG Medication for Hair Loss Product and Services
    • 2.2.4 Bayer AG Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bayer AG Recent Developments/Updates
  • 2.3 J&J
    • 2.3.1 J&J Details
    • 2.3.2 J&J Major Business
    • 2.3.3 J&J Medication for Hair Loss Product and Services
    • 2.3.4 J&J Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 J&J Recent Developments/Updates
  • 2.4 Taisho Pharma
    • 2.4.1 Taisho Pharma Details
    • 2.4.2 Taisho Pharma Major Business
    • 2.4.3 Taisho Pharma Medication for Hair Loss Product and Services
    • 2.4.4 Taisho Pharma Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Taisho Pharma Recent Developments/Updates
  • 2.5 Organon
    • 2.5.1 Organon Details
    • 2.5.2 Organon Major Business
    • 2.5.3 Organon Medication for Hair Loss Product and Services
    • 2.5.4 Organon Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Organon Recent Developments/Updates
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Medication for Hair Loss Product and Services
    • 2.6.4 Pfizer Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Pfizer Recent Developments/Updates
  • 2.7 P&G
    • 2.7.1 P&G Details
    • 2.7.2 P&G Major Business
    • 2.7.3 P&G Medication for Hair Loss Product and Services
    • 2.7.4 P&G Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 P&G Recent Developments/Updates
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck Medication for Hair Loss Product and Services
    • 2.8.4 Merck Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Merck Recent Developments/Updates
  • 2.9 3SBio
    • 2.9.1 3SBio Details
    • 2.9.2 3SBio Major Business
    • 2.9.3 3SBio Medication for Hair Loss Product and Services
    • 2.9.4 3SBio Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 3SBio Recent Developments/Updates
  • 2.10 DrFormulas
    • 2.10.1 DrFormulas Details
    • 2.10.2 DrFormulas Major Business
    • 2.10.3 DrFormulas Medication for Hair Loss Product and Services
    • 2.10.4 DrFormulas Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 DrFormulas Recent Developments/Updates
  • 2.11 Beijing Hanmi Pharmaceutical Co., Ltd.
    • 2.11.1 Beijing Hanmi Pharmaceutical Co., Ltd. Details
    • 2.11.2 Beijing Hanmi Pharmaceutical Co., Ltd. Major Business
    • 2.11.3 Beijing Hanmi Pharmaceutical Co., Ltd. Medication for Hair Loss Product and Services
    • 2.11.4 Beijing Hanmi Pharmaceutical Co., Ltd. Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Hanmi Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.12 Hims & Hers Health, Inc.
    • 2.12.1 Hims & Hers Health, Inc. Details
    • 2.12.2 Hims & Hers Health, Inc. Major Business
    • 2.12.3 Hims & Hers Health, Inc. Medication for Hair Loss Product and Services
    • 2.12.4 Hims & Hers Health, Inc. Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hims & Hers Health, Inc. Recent Developments/Updates
  • 2.13 Zhejiang Conba Pharmaceutical Co.,Ltd.
    • 2.13.1 Zhejiang Conba Pharmaceutical Co.,Ltd. Details
    • 2.13.2 Zhejiang Conba Pharmaceutical Co.,Ltd. Major Business
    • 2.13.3 Zhejiang Conba Pharmaceutical Co.,Ltd. Medication for Hair Loss Product and Services
    • 2.13.4 Zhejiang Conba Pharmaceutical Co.,Ltd. Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Zhejiang Conba Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.14 Nutraceutical Wellness, Inc.
    • 2.14.1 Nutraceutical Wellness, Inc. Details
    • 2.14.2 Nutraceutical Wellness, Inc. Major Business
    • 2.14.3 Nutraceutical Wellness, Inc. Medication for Hair Loss Product and Services
    • 2.14.4 Nutraceutical Wellness, Inc. Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Nutraceutical Wellness, Inc. Recent Developments/Updates
  • 2.15 Renhe Pharmacy Co.,Ltd.
    • 2.15.1 Renhe Pharmacy Co.,Ltd. Details
    • 2.15.2 Renhe Pharmacy Co.,Ltd. Major Business
    • 2.15.3 Renhe Pharmacy Co.,Ltd. Medication for Hair Loss Product and Services
    • 2.15.4 Renhe Pharmacy Co.,Ltd. Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Renhe Pharmacy Co.,Ltd. Recent Developments/Updates
  • 2.16 Teva Pharmaceuticals
    • 2.16.1 Teva Pharmaceuticals Details
    • 2.16.2 Teva Pharmaceuticals Major Business
    • 2.16.3 Teva Pharmaceuticals Medication for Hair Loss Product and Services
    • 2.16.4 Teva Pharmaceuticals Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.17 Cipla
    • 2.17.1 Cipla Details
    • 2.17.2 Cipla Major Business
    • 2.17.3 Cipla Medication for Hair Loss Product and Services
    • 2.17.4 Cipla Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Cipla Recent Developments/Updates
  • 2.18 RelonChem
    • 2.18.1 RelonChem Details
    • 2.18.2 RelonChem Major Business
    • 2.18.3 RelonChem Medication for Hair Loss Product and Services
    • 2.18.4 RelonChem Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 RelonChem Recent Developments/Updates
  • 2.19 Dr. Reddy
    • 2.19.1 Dr. Reddy Details
    • 2.19.2 Dr. Reddy Major Business
    • 2.19.3 Dr. Reddy Medication for Hair Loss Product and Services
    • 2.19.4 Dr. Reddy Medication for Hair Loss Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Dr. Reddy Recent Developments/Updates

3 Competitive Environment: Medication for Hair Loss by Manufacturer

  • 3.1 Global Medication for Hair Loss Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medication for Hair Loss Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medication for Hair Loss Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medication for Hair Loss by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medication for Hair Loss Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medication for Hair Loss Manufacturer Market Share in 2025
  • 3.5 Medication for Hair Loss Market: Overall Company Footprint Analysis
    • 3.5.1 Medication for Hair Loss Market: Region Footprint
    • 3.5.2 Medication for Hair Loss Market: Company Product Type Footprint
    • 3.5.3 Medication for Hair Loss Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medication for Hair Loss Market Size by Region
    • 4.1.1 Global Medication for Hair Loss Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medication for Hair Loss Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medication for Hair Loss Average Price by Region (2021-2032)
  • 4.2 North America Medication for Hair Loss Consumption Value (2021-2032)
  • 4.3 Europe Medication for Hair Loss Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medication for Hair Loss Consumption Value (2021-2032)
  • 4.5 South America Medication for Hair Loss Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medication for Hair Loss Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 5.2 Global Medication for Hair Loss Consumption Value by Type (2021-2032)
  • 5.3 Global Medication for Hair Loss Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 6.2 Global Medication for Hair Loss Consumption Value by Application (2021-2032)
  • 6.3 Global Medication for Hair Loss Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 7.2 North America Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 7.3 North America Medication for Hair Loss Market Size by Country
    • 7.3.1 North America Medication for Hair Loss Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medication for Hair Loss Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medication for Hair Loss Market Size by Country
    • 8.3.1 Europe Medication for Hair Loss Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medication for Hair Loss Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medication for Hair Loss Market Size by Region
    • 9.3.1 Asia-Pacific Medication for Hair Loss Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medication for Hair Loss Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 10.2 South America Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 10.3 South America Medication for Hair Loss Market Size by Country
    • 10.3.1 South America Medication for Hair Loss Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medication for Hair Loss Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medication for Hair Loss Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medication for Hair Loss Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medication for Hair Loss Market Size by Country
    • 11.3.1 Middle East & Africa Medication for Hair Loss Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medication for Hair Loss Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medication for Hair Loss Market Drivers
  • 12.2 Medication for Hair Loss Market Restraints
  • 12.3 Medication for Hair Loss Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medication for Hair Loss and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medication for Hair Loss
  • 13.3 Medication for Hair Loss Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medication for Hair Loss Typical Distributors
  • 14.3 Medication for Hair Loss Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medication for Hair Loss. Industry analysis & Market Report on Medication for Hair Loss is a syndicated market report, published as Global Medication for Hair Loss Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medication for Hair Loss market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo